4.6 Article

Decision Regret following Breast Reconstruction: The Role of Self-Efficacy and Satisfaction with Information in the Preoperative Period

Journal

PLASTIC AND RECONSTRUCTIVE SURGERY
Volume 132, Issue 5, Pages 724E-734E

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PRS.0b013e3182a3bf5d

Keywords

-

Categories

Funding

  1. American Society of Clinical Oncology
  2. Conquer Cancer Foundation Career Development Award
  3. Wharton Chair in Plastic and Reconstructive Surgery at the University Health Network
  4. Canadian Breast Cancer Foundation
  5. Canadian Institutes of Health Research

Ask authors/readers for more resources

Background: The relationship between satisfaction with information and decision regret has not been previously studied in breast reconstruction patients. The objective of this study, therefore, was to assess this relationship and the factors that may influence satisfaction with preoperative information, including self-efficacy (confidence with seeking medical knowledge). Methods: All patients who underwent breast reconstruction between January of 2009 and March of 2011 were approached to complete the Modified Stanford Self-Efficacy Scale (1 to 10), the satisfaction with information subscale of the BREAST-Q (1 to 100), and the Decision Regret Scale (1 to 100). Two multinomial logistic regression models were built to assess the relationship between patient-reported satisfaction with information and decision regret, and to evaluate the relationship among satisfaction with information, self-efficacy level, and sociodemographic characteristics. Results: In 100 participants (71 percent response rate), the mean Decision Regret Scale score was 9.3 17.3 of 100, and the majority of patients experienced no regret (60 percent). We found that regret was significantly reduced when patients were more satisfied with the preoperative information that they received from their plastic surgeons ( = 0.95; 95 percent CI, 0.93 to 0.96). Furthermore, patients reported higher satisfaction with information when they possessed more self-efficacy irrespective of their sociodemographic characteristics ( = 1.06; 95 percent CI, 1.04 to 1.09). Conclusions: Patients who possess lower levels of self-efficacy are at greater risk for experiencing dissatisfaction with the information that they receive in the preoperative period, and ultimately suffered more regret over their decision to undergo breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, IV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Correction Oncology

Survival from breast cancer in women with a BRCA2 mutation by treatment (vol 124, pg 1524, 2021)

D. Gareth Evans, Kelly-Anne Phillips, Roger L. Milne, Robert Fruscio, Cezary Cybulski, Jacek Gronwald, Jan Lubinski, Tomasz Huzarski, Zerin Hyder, Claire Forde, Kelly Metcalfe, Leigha Senter, Jeffrey Weitzel, Nadine Tung, Dana Zakalik, Maria Ekholm, Ping Sun, Steven A. Narod

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

Kelly A. Metcalfe, Jacek Gronwald, Nadine M. Tung, Jeanna M. McCuaig, Andrea Eisen, Christine Elser, William D. Foulkes, Susan L. Neuhausen, Leigha Senter, Pal Moller, Louise Bordeleau, Robert Fruscio, Lea Velsher, Dana Zakalik, Olufunmilayo Olopade, Charis Eng, Tuya Pal, Carey A. Cullinane, Fergus J. Couch, Joanne Kotsopoulos, Ping Sun, Jan Lubinski, Steven A. Narod

Summary: The study aimed to estimate the cumulative risks of all cancers in women aged 50 to 75 with a BRCA1 or BRCA2 gene mutation. The results showed that women with BRCA1 or BRCA2 mutations have a high risk of cancer, particularly breast and ovarian cancer, between the ages of 50 and 75. Therefore, appropriate counseling should be provided to these women.

CANCER (2023)

Article Genetics & Heredity

Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer

Jeanna M. McCuaig, Tracy L. Stockley, Sarah E. Ferguson, Danielle Vicus, Sarah Brennenstuhl, Karen Ott, Raymond H. Kim, Kelly A. Metcalfe

Summary: This study evaluated the psychological outcomes following tumor and germline genetic testing in individuals with HGSOC. The results showed a significant decrease in genetic testing-related distress following receipt of germline results with genetic counseling. Most individuals were satisfied with this model of care.

JOURNAL OF GENETIC COUNSELING (2023)

Article Oncology

Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?

Kelly A. Metcalfe, Steven A. Narod, Andrea Eisen, Aletta Poll, Neda Zamani, David McCready, Tulin D. Cil, Frances C. Wright, Jordan Lerner-Ellis, Jeanna McCuaig, Tracy Graham, Ping Sun, Mohammad R. Akbari

Summary: The objective of this study was to evaluate the pathogenic variant yield for nine cancer predisposition genes by testing criteria. Results showed that of the 1006 women studied, 100 women (9.9%) were found to have a pathogenic variant in one of the nine genes tested. The highest prevalence of pathogenic variants was found in women with triple-negative breast cancer (23%).

CANCER MEDICINE (2023)

Article Oncology

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation

Joanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, Amber Aeilts, Susan Randall Armel, Beth Karlan, Christian Singer, Andrea Eisen, Nadine Tung, Olufunmilayo Olopade, Louise Bordeleau, Charis Eng, William Foulkes, Susan Neuhausen, Carey Cullinane, Tuya Pal, Robert Fruscio, Jan Lubinski, Kelly Metcalfe, Ping Sun, Steven Narod

Summary: The use of selective estrogen receptor modulators like tamoxifen or raloxifene may be effective in reducing the risk of breast cancer in women with BRCA mutations. However, further research is needed to confirm these findings.

BREAST CANCER RESEARCH AND TREATMENT (2023)

Article Oncology

Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial

Kelly A. Metcalfe, Tuya Pal, Steven A. Narod, Susan Armel, Salma Shickh, Kathleen Buckley, Scott T. Walters, Sarah Brennenstuhl, Anita Y. Kinney

Summary: This study aimed to evaluate the effect of a theory-based behavioral intervention delivered by genetic counselors on the uptake of risk-reducing salpingo-oophorectomy (RRSO) by women with BRCA1 or BRCA2 pathogenic variants (PVs) compared to usual care. Findings showed that the intervention significantly reduced decisional conflict and increased knowledge at one-year, and resulted in a higher proportion of RRSO at two years compared to usual care.

CANCER MEDICINE (2023)

Article Surgery

Patient Outcomes after Fat Grafting to the Radiated Chest Wall before Delayed Two-stage Alloplastic Breast Reconstruction

Robert Wenger, Helene Retrouvey, Kelly Metcalfe, John L. Semple

Summary: This study assessed the outcomes of fat grafting before two-stage implant-based breast reconstruction in patients who had undergone mastectomy and radiation therapy. Results showed that there were no reconstructive failures and the short-term complication rate was 5%. Two patients developed capsular contracture grade IV and four patients required additional fat grafting for contour deformities.

PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2023)

Meeting Abstract Oncology

Comparison of thirty-year population-based incidence rates of invasive lobular vs ductal vs mixed breast carcinoma in Ontario, Canada

David Wai Lim, Vasily Giannakeas, Steven Narod, Kelly A. Metcalfe

CANCER RESEARCH (2023)

Meeting Abstract Oncology

Population-based survival outcomes of pure vs mixed invasive lobular breast carcinoma in Ontario, Canada

David Lim, Vasily Giannakeas, Steven Narod, Kelly Metcalfe

CANCER RESEARCH (2023)

Meeting Abstract Oncology

Prevalence of Pathogenic Variants in Cancer Predisposition Genes in Women with Young Onset Breast Cancer

Kelly Metcalfe, May Lynn Quan, Steven Narod, Ellen Warner, Christine Friedenreich, Nancy Baxter, Aletta J. Poll, Mohammad Akbari

CANCER RESEARCH (2023)

Article Oncology

A Qualitative Study of the Everyday Impacts of Cognitive Difficulties After Stem Cell Transplantation

Samantha J. Mayo, Isabel Wozniczka, Beth Edwards, Sean B. Rourke, Doris Howell, Kelly A. Metcalfe, Arta Taghavi Haghayegh, Jeffrey H. Lipton

Summary: This study explores how cognitive difficulties affect the everyday lives of survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT). The findings show that cognitive symptoms change the experience of everyday tasks, provoke emotional responses, and lead to the adoption of mitigation strategies. These findings have implications for developing patient-centered approaches to assessing and managing cognitive difficulties.

ONCOLOGY NURSING FORUM (2022)

Review Oncology

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention

Lauren C. Tindale, Almira Zhantuyakova, Stephanie Lam, Michelle Woo, Janice S. Kwon, Gillian E. Hanley, Bartha Knoppers, Kasmintan A. Schrader, Stuart J. Peacock, Aline Talhouk, Trevor Dummer, Kelly Metcalfe, Nora Pashayan, William D. Foulkes, Ranjit Manchanda, David Huntsman, Gavin Stuart, Jacques Simard, Lesa Dawson

Summary: Individuals with hereditary cancer syndrome have increased risk of ovarian, breast, and other types of cancers. However, most high-risk individuals in Canada are unaware of their risk. To address this issue, the British Columbia Gynecologic Cancer Initiative organized a research summit to explore the potential of population-based genetic testing in preventing hereditary cancer and reducing morbidity and mortality.

CURRENT ONCOLOGY (2022)

Review Oncology

Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature

Lindsay Carlsson, Emily Thain, Brittany Gillies, Kelly Metcalfe

Summary: This review evaluates the psychological and health behavior outcomes associated with multi-gene panel testing for hereditary breast and ovarian cancer (HBOC) risk. Individuals with a pathogenic variant (PV) reported higher levels of testing-related concerns, cancer-specific distress, and uptake of prophylactic surgery compared to those with variant of uncertain significance (VUS) or negative result. The impact of gene penetrance on patient-reported and clinical outcomes remains limited and conflicting.

HEREDITARY CANCER IN CLINICAL PRACTICE (2022)

Meeting Abstract Oncology

Impact of Reconstruction Type and Timing on Psychosocial Outcomes Following Post-Mastectomy Radiotherapy.

David W. Lim, Helene Retrouvey, Isabel Kerrebijn, Benita Hosseini, Anne O'Neill, Tulin Cil, Toni Zhong, Stefan Hofer, David McCready, Kelly Metcalfe

ANNALS OF SURGICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Preparing to survive: Improving outcomes for young women with breast cancer from diagnosis, throughout treatment and into survivorship

Alison Hunter-Smith, Colleen Cuthbert, Karen Fergus, Lisa Barbera, Yvonne Efegoma, Doris Howell, Susan Isherwood, Nathalie Levasseur, Adena Scheer, Christine Simmons, Amirrtha Srikantham, Claire Temple-Oberle, Yuan Xu, Kelly Metcalfe, May-Lynn Quan

ANNALS OF SURGICAL ONCOLOGY (2022)

No Data Available